Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Zumedha - Investments

Research · Analysis · Insights

Zumedha - Investments

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
Close

Search

Zumedha - Investments

Research · Analysis · Insights

Zumedha - Investments

Research · Analysis · Insights

  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
  • Home
  • Stocks Analysis
    • Metals
    • Auto Sector
      • Auto Components
    • Banking & Finance
    • Aviation
    • Power & Energy
      • Cables & Wires
      • Battery Industries
    • IT & Tech
      • IT Services
      • Technology
      • BioTech Stocks
      • Bio Science
    • Infrastructure Sector
    • Telecom
    • Hotels & Hospitality
    • Travel & Hospitality
    • Healthcare
      • Pharmaceutical Stocks
    • Quick COmmerce
    • Consumer Services
    • EMS Stocks
  • Mutual Funds
    • SmallCap Mutual Funds
  • Master Class
Close

Search

Home/Auto Components/Exide Industries DCF Value Analysis March 2026
Auto ComponentsBattery Industries

Exide Industries DCF Value Analysis March 2026

April 1, 2026 7 Min Read
Updated on April 6, 2026
Exide Industries — Investment Research Report
Equity Research NSE: EXIDEIND| BSE: 500086| Sector: Auto Components / Batteries| March 31, 2026
CMP ₹300.85
52W High ₹431.00
52W Low ₹295.50
Mkt Cap ₹25,572 Cr
P/E (TTM) 31.7x
1Y Return −10.9%
Div. Yield 0.67%
In-Depth Equity Analysis · Lead-Acid & Li-Ion Batteries
Exide Industries Ltd.
India’s Dominant Battery Maker at an Inflection Point
Founded in 1916 and listed since 1995, Exide Industries commands India’s largest lead-acid battery franchise across automotive, industrial, and solar verticals. The company is now executing a multi-thousand-crore pivot toward lithium-ion energy storage through its wholly-owned subsidiary Exide Energy Solutions Ltd (EESL). With the stock down ~28% over six months and trading near its 52-week low, this report assesses whether the selloff has created a genuine opportunity — or if structural challenges justify the discount.
Revenue (FY25)
₹16,588 Cr
+3.6% 5Y CAGR (standalone)
PAT (FY25)
₹1,077 Cr
vs ₹1,053 Cr in FY24
EPS (TTM)
₹9.27
Q3 FY26 EPS: ₹1.84
EBITDA (FY25)
₹1,893 Cr
EBITDA Margin ~11.4%
P/B Ratio
1.81x
vs 3Y avg ROE 6.64%
Debt / Equity
0.0x
Near-zero leverage
Promoter Holding
46.0%
Stable; no pledge
Li-Ion Capex (EESL)
₹4,802 Cr
Invested to date (Mar 2026)
Business Overview
01

Exide Industries Limited is India’s largest lead-acid storage battery manufacturer with over 109 years of operating history. Originally incorporated as Chloride Industries Ltd, it was rechristened in August 1995. The company operates 10 factories across five Indian states, of which 8 manufacture lead-acid batteries and 2 produce Home UPS Systems. It also has manufacturing facilities in Sri Lanka, Singapore, and the UK.

The business is organized into two primary segments: Automotive (contributing ~70% of sales) and Industrial (~30%). Within automotive, the company serves OEMs directly and the replacement aftermarket — the latter delivering better margins and constituting the backbone of earnings stability. Its brands — Exide, SF Sonic, PowerSafe, and Dynex — are deeply embedded in India’s retail battery ecosystem with over 2,200 customer touchpoints and distribution across 60+ countries.

The strategic pivot underway is toward lithium-ion batteries through Exide Energy Solutions Ltd (EESL), a wholly-owned subsidiary. Exide has now invested ₹4,802 crore into EESL as of March 2026, funding a Gigafactory in Bengaluru in partnership with technology licensor SVOLT Energy. MoUs are in place with Hyundai Motor and Kia Corp to supply EV batteries. This gives Exide a potential first-mover advantage in domestic lithium-ion cell manufacturing — a critical strategic asset if India’s EV transition accelerates.

Historical Financial Performance
02
Standalone Financials — ₹ Crore
MetricFY22FY23FY24FY25Q3 FY26
Revenue13,28014,84015,95616,5884,201
EBITDA1,3401,5401,7601,893~482
EBITDA Margin %10.1%10.4%11.0%11.4%~11.5%
PAT7408221,0531,077~575 (9M)
PAT Margin %5.6%5.5%6.6%6.5%~6.8%
EPS (₹)6.166.848.768.969.27 (TTM)

Revenue growth has been modest — a 5-year CAGR of 3.56% — underperforming the industry average of 7.42%. However, margin trajectory has been encouraging, with EBITDA margins expanding ~130 bps from FY22 to FY25. PAT grew sharply from FY22 to FY24 (+42%) before plateauing in FY25 due to higher depreciation and capex at EESL. The Q3 FY26 standalone quarterly PAT of ₹195 crore represents 23.7% YoY growth, suggesting operating momentum is intact.

Quarterly Snapshot (FY26)
QuarterRevenue (₹ Cr)PAT (₹ Cr)PAT Growth YoYEPS (₹)
Q1 FY264,695273+37.4%3.21
Q2 FY264,445298+3.8%3.50
Q3 FY264,201195+23.7%1.84*

*Q3 EPS from StockInvest; may differ from annualized TTM EPS of ₹9.27. Revenue sequentially declining due to seasonal automotive slowdown.

DCF Valuation
03
DCF
10-Year Free Cash Flow Model
₹900 Cr
12.0%
5.0%
10–12%
7–8%
852 Cr
₹11,400 Cr
₹15,200 Cr
₹310–₹340
Model excludes incremental value from EESL (Li-Ion) which carries execution risk. If EESL scales successfully to ~10 GWh revenue, adds ₹40–₹60/share optionality. WACC sensitivity: at 11%, intrinsic value rises to ₹360; at 13%, falls to ₹280. Base FCF is conservative — actual FY25 FCF was impacted by ₹1,000 Cr EESL capex.
Buy Range
04

At current levels near ₹300, the stock trades at a marginal discount to our DCF intrinsic value of ₹310–₹340. Given near-zero debt, strong cash generation from the legacy lead-acid business, and the optionality from EESL, staged accumulation at these levels is warranted for long-term investors.

Strong Buy
₹260–₹285
Deep value; 15–20% discount to intrinsic. Aggressive accumulation zone.
Accumulate
₹285–₹315
Current zone. Fair entry for 2–3 year horizon with EESL optionality.
Fair Value / Watch
₹315–₹350
Limit fresh buying. Await earnings catalyst or EESL commercial milestone.
Buy Scenario Analysis
05
🐻 Bear Case
₹240
OEM automotive demand remains weak; EESL faces execution delays beyond FY28; lead prices spike; margins compress to 9.5%. EPS ₹7.5 × 32x P/E.
📊 Base Case
₹380
Steady 8–10% revenue CAGR; EBITDA margin 11.5–12%; EESL begins initial production by FY27. EPS ₹12.5 × 30x P/E. 12-month target.
🐂 Bull Case
₹480
EESL secures large EV OEM contracts; Li-Ion margins surprise; automotive replacement booms. EPS ₹16 × 30x P/E. Re-rating to 35x possible.
Sell Range
06

Given the structural transformation underway and heavy capex cycle, investors should consider trimming positions as the stock approaches our fair value ceiling or if near-term earnings disappoint materially without a clear EESL catalyst to compensate.

Reduce
₹390–₹420
Above base case; trim 25–30% of position. Lock gains; re-enter on corrections.
Exit / Book
₹420–₹450
Full exit unless EESL commercialization provides clear incremental earnings visibility.
Avoid / Short
> ₹450
Overvalued relative to lead-acid base; implies P/E > 45x with no Li-Ion earnings yet.
Sell Scenario Analysis
07
⚠️ Overvalued
₹420
Stock prices in EESL success prematurely. Rich P/E leaves no margin of safety; initiate reduce.
🔴 Exit Trigger
₹450
Lead-acid growth slowing; EESL commercial launch delayed post-FY28; earnings miss consensus for 2 quarters.
💀 Structural Break
> ₹450
Chinese battery dumping threatens domestic pricing; EV transition faster than anticipated rendering lead-acid obsolete.
Future Growth & Earnings Potential
08

Exide’s growth story has two distinct chapters: the steady, cash-generative lead-acid core, and the high-risk, high-reward lithium-ion venture.

Lead-Acid Core: India’s vehicle parc is expected to grow at 6–8% annually through 2030. The replacement battery cycle (typically 3–5 years) provides annuity-like demand, with margins superior to OEM supply. Industrial batteries benefit from the data center boom (power backup), solar storage adoption, and telecom tower densification. Export business (~8–9% of revenue) is growing despite a setback in European industrial markets.

EESL — The Strategic Wildcard: Exide Energy Solutions is targeting a 6–12 GWh lithium-ion Gigafactory in Bengaluru, funded by the ₹4,802 crore invested to date. Technology partnerships with SVOLT (China) and MoUs with Hyundai/Kia provide credibility. If EESL successfully begins production by FY27–28 and ramps to commercial scale, it could add ₹2,000–₹4,000 Cr in annual revenues by FY30 — potentially transforming Exide’s growth trajectory from mid-single-digit to mid-double-digit.

MetricFY25AFY26EFY27EFY28E
Revenue (₹ Cr)16,58817,20018,90021,500
EBITDA Margin11.4%11.5%12.0%12.5%
PAT (₹ Cr)1,0771,1501,3401,620
EPS (₹)8.969.5511.1213.46
P/E at CMP ₹30033.5x31.4x27.0x22.3x

Estimates are projections based on consensus guidance and management commentary. EESL revenues not included in FY26–27E; incorporated from FY28E.

Risks & Catalysts
09
🟢 Bull Catalysts
  • EESL Bengaluru plant achieves commercial production milestone ahead of schedule (FY27)
  • Large EV OEM supply contract win by EESL (beyond Hyundai/Kia MoU)
  • Lead prices stabilize or fall, boosting margins by 50–100 bps
  • Strong replacement cycle driven by aging vehicle parc; market share gains from unorganized players
  • Solar and data center UPS demand surges, diversifying industrial revenue
  • Government PLI incentives for domestic battery manufacturing benefit EESL capex returns
  • Margin improvement as EESL shifts from capex to production (depreciation absorption)
🔴 Bear Risks
  • EESL execution delays — technology transfer, ramp, or off-take uncertainty beyond FY28
  • Lead price volatility (key raw material) compressing already-thin margins
  • OEM automotive demand weakness persists; car inventory correction continues
  • Amara Raja accelerates Li-Ion via Gotion partnership, diluting EESL’s first-mover edge
  • Chinese battery imports (dumping risk) undercut domestic pricing post-EV scale
  • ROE structurally depressed at 6.6% due to heavy EESL investment without near-term returns
  • Technology change risk: LFP vs NMC preference shift could render SVOLT tie-up suboptimal
Peer Comparison
10
CompanyMkt Cap (₹ Cr)Revenue (₹ Cr)P/E (TTM)P/BEBITDA Margin5Y Rev CAGR
Exide Industries (EXIDEIND)25,57216,58831.7x1.81x11.4%3.6%
Amara Raja Energy (ARE&M)~16,200~12,400~22x~2.0x~13.5%~7.5%
HBL Engineering~5,800~2,200~38x~5.5x~14%~12%
Eveready Industries~2,100~1,650~30x~4.0x~8.5%~3%
Sector Avg——~28x~2.8x~12%~7.4%

Exide trades at a premium P/E of 31.7x despite below-sector revenue growth and below-sector EBITDA margins. The premium is being paid for brand leadership, balance sheet purity (zero debt), and EESL optionality. Amara Raja offers a more attractive near-term earnings profile with higher margins and faster growth, but Exide’s larger scale and established EESL infrastructure give it a long-term advantage if Li-Ion commercializes. At the current compressed price level, Exide’s risk-reward is more balanced than at the ₹430+ highs.

Investment Verdict
Accumulate on Weakness — High-Conviction Long-Term Bet
Exide Industries offers a compelling risk-reward at current levels near its 52-week low of ₹295. The core lead-acid business generates ₹900+ Cr in free cash flow annually, the balance sheet is pristine with zero debt, and the replacement-cycle moat is intact. The EESL lithium-ion bet is binary in the short term but transformative over a 5-year horizon. At ₹300, the stock is pricing in substantial pessimism about EESL execution while the core franchise is being undersold. Our 12-month base case target of ₹380 implies ~26% upside. Long-term investors (3–5 year horizon) should accumulate in the ₹285–₹315 zone with a stop-loss below ₹260. Avoid lump-sum at higher levels; prefer SIP-style accumulation.
Rating
ACCUMULATE
Target: ₹380
Horizon: 12M
Stop: ₹260
DISCLAIMER: This report is prepared for informational and educational purposes only. It does not constitute investment advice, a solicitation, or an offer to buy or sell any security. The author/publisher is not a SEBI-registered research analyst. All financial data has been sourced from publicly available filings, exchange disclosures, and third-party databases; while care has been taken to ensure accuracy, no guarantees are provided. Investment in equities involves substantial risk of loss, including possible loss of principal. Past performance is not indicative of future results. Readers are advised to consult a qualified financial advisor before making any investment decision. Valuations, price targets, and projections are based on assumptions that may not materialize. The author may or may not hold positions in the securities mentioned. Please invest responsibly.

Tags:

Exide
Author

Zumedha Research Team

Follow Me
Other Articles
Previous

Coal India Share Value Analysis March 2026

Next

YES Bank DCF Value Analysis March 2026

Recent Posts

  • DCF (Discounted Cash Flow)
  • HDFC Bank (NSE: HDFCBANK) — Stock Analysis April 2026
  • Buy vs Accumulate Rating in Stocks: Key Differences Every Investor Must Know
  • Persistent Systems Value Analysis April 2026
  • Infosys Ltd Share Value Analysis 2026
Legal Disclaimer Investment Research & Information

Not Investment Advice. All content published on this website — including stock analyses, mutual fund reviews, DCF models, valuation estimates, buying zones, and commentary — is created for our own educational, internal research and informational purposes only. Nothing on this website constitutes financial, investment, legal, or tax advice, nor a solicitation or recommendation to buy, sell, or hold any security or financial instrument.

No Guarantees. It is advised clearly and categorically not o follow these analysis and information blindly for your equity investement purpose as Equity investments and mutual funds are subject to market risks. Past performance is not indicative of future results. All DCF models, fair value estimates, and scenario analyses are based on publicly available data and the author's independent assumptions and may prove materially incorrect. The author/s or owners of this website/portal do not are not liable in whatsoever manner for any positive or negative outcome from your own investment endeavorsYou may lose part or all of your invested capital.

Do Your Own Research. Readers are strongly advised to consult a SEBI-registered investment advisor and conduct their own due diligence before making any investment decision. The author may or may not hold positions in securities discussed on this website.

No Obligations. We, the author/ the publisher/ anybody associated with Zumedha.com does not guarantee the accuracy, adequacy or completeness of any information/data and is not responsible for any errors or omissions or for the results obtained from the use of such information/data. Zumedha.com or anyone involved with zumedha.com will not accept any liability for loss or damage as a result of reliance on the Estimates data. It does not subscribe or endorse any of the services and/or content offered by such third party.

Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
This website is not registered as an Investment Adviser under SEBI (Investment Advisers) Regulations, 2013. All views are personal and for informational purposes only.
© 2026 · All Rights Reserved · For Educational Use Only. RESEARCH · ANALYSIS · INSIGHTS